Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Acupunct Meridian Stud. 2011 Mar;4(1):61-8. doi: 10.1016/S2005-2901(11)60008-3.

Case series of non-small cell lung cancer treated with mountain Ginseng pharmacopuncture.

Author information

  • 1Research Center of Korean Pharmacopuncture Institute, Seoul, Korea. Beevenom@paran.com

Abstract

This study aims to observe the efficacy of mountain Ginseng (Panax ginseng C.A. Meyer) pharmacopuncture (MGP) on cancer patients using different delivery methods of acupoint injection and intravenous infusion. Six non-small cell lung cancer (NSCLC) patients who met the eligibility criteria were observed. Two patients were continuously infused with MGP (20 mL/day) intravenously, and the other two patients were injected with MGP (10 mL/day) on acupoint LU1 bi-lateral continuously. The remaining two patients received MGP therapy using both methods of delivery. Results were followed by computed tomography (CT) after every cycle; each cycle lasted for 28 days. Two patients infused intravenously showed stable disease and two patients injected on LU1 showed progressive disease. Two patients treated using both methods showed stable disease during the intravenous infusion period and progressive disease during the intraacupuncture injection period. One patient showed progressive disease in the latest chest CT in spite of receiving MGP intravenous infusion. We suggested that MGP may be more effective when used as an intravenous infusion rather than acupoint injection in NSCLC patients.

Copyright © 2011 Korean Pharmacopuncture Institute. Published by .. All rights reserved.

PMID:
21440881
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk